0001104659-21-005393.txt : 20210219 0001104659-21-005393.hdr.sgml : 20210219 20210119165825 ACCESSION NUMBER: 0001104659-21-005393 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20210119 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Passage BIO, Inc. CENTRAL INDEX KEY: 0001787297 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 822729751 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: TWO COMMERCE SQUARE STREET 2: 2001 MARKET STREET, 28TH FLOOR CITY: PHILADELPHIA STATE: PA ZIP: 19103 BUSINESS PHONE: 2678660312 MAIL ADDRESS: STREET 1: TWO COMMERCE SQUARE STREET 2: 2001 MARKET STREET, 28TH FLOOR CITY: PHILADELPHIA STATE: PA ZIP: 19103 CORRESP 1 filename1.htm

Passage Bio, Inc.

2001 Market Street, 28th Floor

Philadelphia, PA 19103

January 19, 2021

VIA EDGAR

United States Securities and Exchange Commission
Division of Corporation Finance

100 F Street, NE
Washington, DC 20549

Attention:	Tim Buchmiller

Re:	Passage Bio, Inc. Registration Statement on Form S-1 (File No. 333-252213) originally filed January 19, 2021.

Requested Date: January 21, 2021

Requested Time: 4:30 PM Eastern Time

Ladies and Gentlemen:

Passage Bio, Inc. (the “Registrant”) hereby requests that the Securities and Exchange Commission take appropriate action to declare the above-captioned Registration Statements on Form S-1 effective at the “Requested Date” and “Requested Time” set forth above or as soon thereafter as practicable.

The Registrant hereby authorizes Robert A. Freedman or Ryan Mitteness, both of whom are attorneys with the Registrant’s outside legal counsel, Fenwick & West LLP, to orally modify or withdraw this request for acceleration.

The Registrant requests that it be notified of such effectiveness by a telephone call to Mr. Freedman at (650) 335-7292 or, in his absence, Mr. Mitteness at (206)-389-4533.

* * *

	Sincerely,

	passage bio, inc.

	By:	/s/ Bruce Goldsmith
		Bruce Goldsmith, Ph.D.
		Chief Executive Officer

cc:	Richard S. Morris, Chief Financial Officer
	Passage Bio, Inc.

	Ryan Mitteness, Esq.
	Robert A. Freedman, Esq.
	Fenwick & West LLP